Admission Samples in a Residual-THC Study Were Not Automatically Baseline Measurements
The first sample collected after admission to detoxification is not automatically a stable residual-THC baseline. In a study of heavy cannabis users, some participants had smoked only an hour or two before entering treatment. The investigators explicitly cautioned against treating every first-day result as a baseline concentration.
Admission and last use were different reference points
Odell and colleagues recruited 21 cannabis-dependent adults from two residential treatment units in Melbourne. Participants were asked to provide blood, urine and oral fluid daily for seven days. The study addressed real-world heavy use, rather than administering the same controlled cannabis dose to every participant.
Time of last use came from participants’ histories. Collection timing also varied with nursing-staff availability. Consequently, the first sample did not represent an identical interval after exposure across the group. Labeling it an admission sample describes its place in the study; it does not establish that absorption and redistribution had ended.
A residential setting did not resolve every abstinence question
The setting supported observation during treatment, but the authors acknowledged that reported last-use times could not be verified. They also discussed possible clandestine cannabis use when interpreting a later blood-THC increase in one participant. That possibility should remain visible when the paper is used as evidence about residual concentrations.
The authors did not demonstrate that re-exposure caused every later increase. They considered several possible explanations for changing concentrations, including release from body stores. The useful conclusion is that an unusual trajectory was not uniquely diagnostic of either residual release or renewed use.
A negative oral-fluid sample did not settle the timing
In the participant with the substantial later blood rise, oral fluid did not contain detected THC at that sampling time. The authors nevertheless explained that this did not exclude use during the interval since the preceding sample. A negative result at one collection cannot continuously document what happened between collections.
The analytes also differed across matrices: the investigators measured parent THC in whole blood and oral fluid, but THC-COOH in urine. Those measurements cannot be substituted for one another. Urine creatinine was not measured, preventing correction of urinary concentrations for dilution.
The complete dataset was smaller than enrollment
Only 11 participants supplied a full set of seven blood, urine and oral-fluid collections. Some participants left early or did not provide every specimen. The number enrolled therefore should not be presented as the number contributing complete observations at every time point.
Most participants were also taking other medications. The authors could not exclude drug interactions and did not establish whether persistent concentrations corresponded to persistent psychomotor impairment. This was a concentration study, not a demonstration that every participant remained impaired or had recovered at a specified time.
Applying the study to an individual result
The paper contributes evidence that concentration patterns in heavy users can be prolonged and variable. Its admission measurements, however, are not a universal baseline lookup table. A case-specific comparison should retain reported last use, collection timing, treatment circumstances, missing samples, analytical limits and possible intervening exposure.
This distinction complements our discussion of prior use, recent use, impairment and crash causation. A study’s contribution and its limitations can both be relevant without converting one measurement into proof of all four propositions.
Research reference
Odell MS, Frei MY, Gerostamoulos D, Chu M, Lubman DI. Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use. Forensic Science International. 2015;249:173–180. doi:10.1016/j.forsciint.2015.01.026. Evidence basis: the supplied paper’s abstract, methods, results and limitations.
